Brenda Libby Coleman

Array ( [id] => 6788150 [patent_doc_number] => 20030139389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => '5-HT4 receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/317159 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6377 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139389.pdf [firstpage_image] =>[orig_patent_app_number] => 10317159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580898 [patent_doc_number] => 07452912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => utility [patent_app_number] => 10/316189 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29711 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452912.pdf [firstpage_image] =>[orig_patent_app_number] => 10316189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910383 [patent_doc_number] => 07329654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/307735 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70516 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329654.pdf [firstpage_image] =>[orig_patent_app_number] => 10307735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835413 [patent_doc_number] => 20030162959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Method for the preparation of 6alpha-fluoro corticosteroids' [patent_app_type] => new [patent_app_number] => 10/305138 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5245 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162959.pdf [firstpage_image] =>[orig_patent_app_number] => 10305138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92265 [patent_doc_number] => 07732437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Use of anti-histaminics for acute reduction of elevated intracranial pressure' [patent_app_type] => utility [patent_app_number] => 10/494006 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13498 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732437.pdf [firstpage_image] =>[orig_patent_app_number] => 10494006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 449409 [patent_doc_number] => RE039743 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-07-24 [patent_title] => '2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use' [patent_app_type] => reissue [patent_app_number] => 10/302324 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4185 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039743.pdf [firstpage_image] =>[orig_patent_app_number] => 10302324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609790 [patent_doc_number] => 06998399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-14 [patent_title] => '4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 10/495935 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2415 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998399.pdf [firstpage_image] =>[orig_patent_app_number] => 10495935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750084 [patent_doc_number] => 07022697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => '4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 10/495891 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2866 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022697.pdf [firstpage_image] =>[orig_patent_app_number] => 10495891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061766 [patent_doc_number] => 20050004128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => '4-(Oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 10/495936 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2450 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004128.pdf [firstpage_image] =>[orig_patent_app_number] => 10495936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061741 [patent_doc_number] => 20050004103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => '4,4-Difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof' [patent_app_type] => utility [patent_app_number] => 10/495494 [patent_app_country] => US [patent_app_date] => 2002-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22916 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004103.pdf [firstpage_image] =>[orig_patent_app_number] => 10495494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 691537 [patent_doc_number] => 07074921 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds' [patent_app_type] => utility [patent_app_number] => 10/292093 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8382 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074921.pdf [firstpage_image] =>[orig_patent_app_number] => 10292093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411694 [patent_doc_number] => 07282496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors' [patent_app_type] => utility [patent_app_number] => 10/285940 [patent_app_country] => US [patent_app_date] => 2002-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16487 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282496.pdf [firstpage_image] =>[orig_patent_app_number] => 10285940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518930 [patent_doc_number] => 07973031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity' [patent_app_type] => utility [patent_app_number] => 10/493786 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21642 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973031.pdf [firstpage_image] =>[orig_patent_app_number] => 10493786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 888239 [patent_doc_number] => 07348324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-25 [patent_title] => 'Cyclic amine compounds as CCR5 antagonists' [patent_app_type] => utility [patent_app_number] => 10/273111 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 129250 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348324.pdf [firstpage_image] =>[orig_patent_app_number] => 10273111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 510530 [patent_doc_number] => 07196076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Androgen receptor modulators and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/493013 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22512 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/196/07196076.pdf [firstpage_image] =>[orig_patent_app_number] => 10493013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299905 [patent_doc_number] => 07538104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Photoactivable nitrogen bases' [patent_app_type] => utility [patent_app_number] => 10/491813 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18806 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538104.pdf [firstpage_image] =>[orig_patent_app_number] => 10491813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1281719 [patent_doc_number] => 06642224 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Diazepan derivatives or salts thereof' [patent_app_type] => B1 [patent_app_number] => 10/148544 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19652 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642224.pdf [firstpage_image] =>[orig_patent_app_number] => 10148544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 760980 [patent_doc_number] => 07012041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-14 [patent_title] => 'Phenylpyridazinones' [patent_app_type] => utility [patent_app_number] => 10/261206 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11224 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/012/07012041.pdf [firstpage_image] =>[orig_patent_app_number] => 10261206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411092 [patent_doc_number] => 20040206940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Novel method of preparing nitrogen macrocycles' [patent_app_type] => new [patent_app_number] => 10/490948 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7545 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20040206940.pdf [firstpage_image] =>[orig_patent_app_number] => 10490948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658216 [patent_doc_number] => 20030078261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Prostaglandin agonists' [patent_app_type] => new [patent_app_number] => 10/256198 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48461 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078261.pdf [firstpage_image] =>[orig_patent_app_number] => 10256198 [rel_patent_id] =>[rel_patent_doc_number] =>)